Figure 3
ROC curves for analytes in plasma at transplant day 14 (landmark analysis, cohorts 1 and 2 combined), using the best model analytes given in Table 5 for predicting more severe from less severe GVHD to day 100.
ROC curves for analytes in plasma at transplant day 14 (landmark analysis, cohorts 1 and 2 combined), using the best model analytes given in Table 5 for predicting more severe from less severe GVHD to day 100.
